![David Kirske](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 783 393 $ as of 2026-06-29
David H.
Kirske is currently Chief Financial Officer & Treasurer at X4 Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Kirske was Chief Financial Officer at Stratus Therapeutics, Inc. from 2024 to 2025.
Other former roles include Chief Financial Officer & Vice President at Helix BioMedix, Inc., Treasurer & Controller at Redhook Ale Brewery, Inc., Treasurer & Controller at F5, Inc., and Chief Financial Officer & Executive Vice President at CTI BioPharma Corp.
Education includes undergraduate studies at the University of Puget Sound.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-29 | 167,750 ( 0.18% ) | 783 393 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director of Finance/CFO | 2025-08-11 |
| Companies | Position | End |
|---|---|---|
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Director of Finance/CFO | 2025-08-31 |
| HELIX BIOMEDIX, INC. | Director of Finance/CFO | 2008-06-22 |
Redhook Ale Brewery, Inc.
 Redhook Ale Brewery, Inc. Beverages: AlcoholicConsumer Non-Durables Produces beer | Comptroller/Controller/Auditor | - |
| F5, INC. | Comptroller/Controller/Auditor | - |
| CTI BIOPHARMA CORP. | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 7 |
|---|---|
Helix BioMedix, Inc.
 Helix BioMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes bioactive peptides | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Redhook Ale Brewery, Inc.
Redhook Ale Brewery, Inc. Beverages: AlcoholicConsumer Non-Durables Produces beer | Consumer Non-Durables |
F5, Inc.
 F5, Inc. Packaged SoftwareTechnology Services Manufactures Internet-based software | Technology Services |
University of Puget Sound
 University of Puget Sound Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
